Hypergrowth or Profits? These 3 Stocks Don't Make You Choose
These three companies are all growing like gangbusters and have already reached profitability.
Apple's Coronavirus Weakness Could Mean Investors' Gains
Apple's stock is under pressure thanks to the COVID-19 outbreak, but those losses may be better news for investors.
L Brands Beats Earnings Expectations Before Taking Victoria's Secret Private
Victoria's Secret continued to weigh on sales, but management is hopeful a turnaround is in store with the sale to Sycamore Partners.
Even better, management expects ad-spend growth on its platform to accelerate in 2020.
The pest control company ended the year strong.
The partnership would focus on developing treatments for neurological diseases.
A 2014 deal the company made continued to pay off, while sales overseas were relatively strong.
The third time was no charm for this stock.
The drug enters a crowded market -- but it has a convenient format.
A big jump in Coronavirus cases around the world is creating turmoil in an oil market that's already oversupplied.
The fast-growing SaaS stock ignored the market's drop, thanks to a solid quarterly update.
Square, Zoom Video, and Upwork defied the trend today.
On a brutal day for the broader stock market, the fast-food giant's light earnings guidance overshadowed an otherwise decent report.
The sell-off behind the quickest 10% drop in history could continue.
Restaurant traffic could suffer in the U.S. if the coronavirus spreads locally.
The company has a solid case for share price appreciation in 2020.
The cannabis company appears to have backed out of its arrangement to buy 420 Investments.
Wall Street expects the widening COVID-19 outbreak will lead to a decline in vacation trips.
The LNG export startup will need billions of dollars to fund its export facility. A major prospective partner that was expected to provide a lot of capital now appears to be on the fence.
These oil and gas marine transportation companies finally had some good news for their investors.
The vintage and handmade e-commerce site ended 2019 on a high note and expects more of the same strength this year.
It's the first chewable tablet of its kind to treat heartworm disease, ticks, and fleas.
The 3D printing specialist reported fourth-quarter earnings.